Log In
BCIQ
Print this Print this
 

ATB-352

  Manage Alerts
Collapse Summary General Information
Company Antibe Therapeutics Inc.
DescriptionNSAID-derivative
Molecular Target
Mechanism of ActionNSAID
Therapeutic ModalitySmall molecule
Latest Stage of DevelopmentPreclinical
Standard IndicationPain
Indication DetailsTreat severe acute pain
Regulatory Designation
PartnerKnight Therapeutics Inc.

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
Total Number of DealsTotal Deal ValueTotal Upfront CashTotal Milestone Payments

2

0

0

$20.0M


 Deals Details
Get a free BioCentury trial today